RE: As of the where Sclp stands today with their Compounds.25 Jun 2020 13:13
Morning ,
I noticed on the CRUK site that our combination study recruitment is due to end next month (19.08), is this date set in stone by the regulators? I assume this can be extended due to Covid , this will obviously only be the Uk arm of the trial .
Drac - imo , the likelihood of some sort of deal / partnership which will have a huge positive effect on the Sp in the next 12 mths is high , I personally think it’s likely to be a lot sooner ! We have so much going on and I don’t think the Bod planned it this way but lots of significant news could come in a very short time frame - I thought this year was going to be very interesting but never expected anything like Covid to get in the way , however Covid could actually benefit us considerably! It could validate our approach and cause a lot of interest .
John Chiplin said at the 2016 AGM “ large pharma are a little like oil tankers , they set off in one direction but when they need to change direction it takes an age “ , I think Inan was trying to explain that we believe they are coming around to our way of thinking and their fore our science , he was imo posting articles explaining why certain other approaches are not as effective as our science will hopefully prove to be .
Our Immunobody ( Scib1) results came out when big pharma had had a very high profile vaccine failure and it put big pharma off vaccines , they looked at other avenues and this was when checkpoint inhibitors / combination studies became all the rage , so little ol Scancell had a extremely good dna vaccine but large pharma where not looking and it was for this reason why we decided to run the combination trial .
It seems to me that Inanaco is showing that pharma are now back looking at vaccines which tells me (imo ) that just because we have not had a deal so far , does not mean one or more are not coming !
I personally believe that deals/ partnerships will happen but trying to predict when ? Anyone’s guess !
Hope that helps and that is just my brief take on matters to date .